Physician profile
Ellen Ong
NPI 1639737166
$1,667.59
in general payments reported to CMS, 2019-2025
10 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.92 · 2021: $198 · 2022: $262 · 2023: $750 · 2024: $259 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,173.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $519.43 | 2021-2025 | Acuvue |
| Alcon Vision LLC | $348.89 | 2021-2024 | Wavelight Refractive Suite, Total30 |
| Bausch & Lomb Americas INC. | $248.28 | 2023 | Infuse |
| Sun Pharmaceutical Industries INC. | $152.33 | 2021-2022 | |
| Astellas Pharma US INC | $111.56 | 2024 | Izervay |
| Oyster Point Pharma, INC. | $108.10 | 2023 | Tyrvaya |
| Coopervision INC. | $105.96 | 2021-2023 | Myday Contact Lens, Misight Contact Lens |
| Visioneering Technologies, INC. | $37.21 | 2020-2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.